Mertens LS - Search Results

1

Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?

Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Contieri R, Mertens LS, Claps F, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG. Beijert IJ, et al. Among authors: mertens ls. Int Urol Nephrol. 2024 Apr;56(4):1323-1333. doi: 10.1007/s11255-023-03867-9. Epub 2023 Nov 19. Int Urol Nephrol. 2024. PMID: 37980689

2

Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study.

Mertens LS, Bruin NM, Vegt E, de Blok WM, Fioole-Bruining A, van Rhijn BW, Horenblas S, Vogel WV. Mertens LS, et al. Nucl Med Commun. 2012 Nov;33(11):1195-201. doi: 10.1097/MNM.0b013e3283567473. Nucl Med Commun. 2012. PMID: 22781846 Clinical Trial.

3

Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival.

Mertens LS, Meijer RP, van Werkhoven E, Bex A, van der Poel HG, van Rhijn BW, Meinhardt W, Horenblas S. Mertens LS, et al. World J Urol. 2013 Oct;31(5):1297-302. doi: 10.1007/s00345-012-0916-z. Epub 2012 Aug 9. World J Urol. 2013. PMID: 22875170

4

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S. Mertens LS, et al. J Urol. 2012 Oct;188(4):1108-13. doi: 10.1016/j.juro.2012.06.018. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901581

5

FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer.

Mertens LS, Fioole-Bruining A, van Rhijn BW, Kerst JM, Bergman AM, Vogel WV, Vegt E, Horenblas S. Mertens LS, et al. J Urol. 2013 May;189(5):1687-91. doi: 10.1016/j.juro.2012.11.009. Epub 2012 Nov 6. J Urol. 2013. PMID: 23142689

6

Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.

Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S. Mertens LS, et al. BJU Int. 2013 Oct;112(6):729-34. doi: 10.1111/bju.12109. Epub 2013 Jun 24. BJU Int. 2013. PMID: 23790129

7

Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis.

Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S. Mertens LS, et al. Indian J Nucl Med. 2012 Jul;27(3):145-50. doi: 10.4103/0972-3919.112718. Indian J Nucl Med. 2012. PMID: 23919066 Free PMC article.

8

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone.

Mertens LS, Meijer RP, Meinhardt W, van der Poel HG, Bex A, Kerst JM, van der Heijden MS, Bergman AM, Horenblas S, van Rhijn BW. Mertens LS, et al. BJU Int. 2014 Jul;114(1):67-74. doi: 10.1111/bju.12447. Epub 2014 Jan 17. BJU Int. 2014. PMID: 24053889

9

Induction chemotherapy followed by surgery in node positive bladder cancer.

Meijer RP, Mertens LS, van Rhijn BW, Bex A, van der Poel HG, Meinhardt W, Kerst JM, Bergman AM, Fioole-Bruining A, van Werkhoven E, Horenblas S. Meijer RP, et al. Among authors: mertens ls. Urology. 2014 Jan;83(1):134-9. doi: 10.1016/j.urology.2013.08.082. Epub 2013 Nov 15. Urology. 2014. PMID: 24246329

10

Prostate sparing cystectomy for bladder cancer: 20-year single center experience.

Mertens LS, Meijer RP, de Vries RR, Nieuwenhuijzen JA, van der Poel HG, Bex A, van Rhijn BW, Meinhardt W, Horenblas S. Mertens LS, et al. J Urol. 2014 May;191(5):1250-5. doi: 10.1016/j.juro.2013.11.031. Epub 2013 Nov 25. J Urol. 2014. PMID: 24286830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page